Enterprise Trust & Investment’s CVS Health CVS Stock Holding History

Enterprise Trust & Investment’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$3K	Buy	+36	New	+$3.51K	﹤0.01%	311

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Enterprise Trust & Investment's CVS Position: Q2 2022 in Review

Enterprise Trust & Investment opened a new position in CVS Health (CVS) in Q2 2022: 36 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #311 among its holdings.

2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

Enterprise Trust & Investment held 36 shares of CVS Health worth $3K as of Q2 2022.
CVS Health was a new Enterprise Trust & Investment position in Q2 2022.
CVS Health made up ﹤0.01% of Enterprise Trust & Investment's portfolio in Q2 2022, its #311 holding.
2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.